Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that its Chief Executive Officer, Dr. Roger Crystal, will participate in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference taking place virtually March 15 - March 17. Management will also host investor 1x1 meetings.

32nd Oppenheimer Annual Oppenheimer Healthcare ConferenceMarch 15 – 17, 2022Fireside chat on March 16 at 2:40 pm ET; hosting 1-on-1 meetings

A webcast of the presentation will be accessible on the Opiant website.

About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:Ben Atkins, Opiant(310) 598-5410batkins@opiant.com 

Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Opiant Pharmaceuticals Charts.
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Opiant Pharmaceuticals Charts.